TrialAlimentary pharmacology & therapeutics2019

Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis.

Kwang Jae Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.